AzTrials
AzTrials

Preterm BirthPremiTranSNCT01851668

Preterm Infant Transport Stress (PremiTranS) Study

An observational study of Preterm Birth, run by University of Nottingham at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is an observational pilot study to quantify the amount of vibration, noise, physiological and biochemical instability that premature babies are exposed to during inter-hospital transport. Read more about this study

Who is it for?
Ages 30 minutes to 3 months
Conditions the study is for
Preterm Birth
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
Jun 2013to 1 Sep 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 minutes to 3 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Hospital born preterm infants

Who may be able to join

  • <31 weeks gestation
  • <= 3 days old

Who cannot join

  • major congenital abnormality
  • survival unlikely

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Nottingham University Hospitals NHS Trust

    Nottingham, NG72UH

Other trials in United Kingdom

About this study

Official title: Preterm Infant Transport Stress (PremiTranS) Study - A Feasibility Study of the Impact of Inter-hospital Transport on the Preterm Infant

This is an observational pilot study to quantify the amount of vibration, noise, physiological and biochemical instability that premature babies are exposed to during inter-hospital transport.

Read the detailed description

Neonatal intensive care has advanced significantly in recent years resulting in a marked decrease in mortality, especially in the extremely low birth weight (ELBW) infants (<1000g). However, we have not observed a parallel improvement in long term outcomes such as neurological disability as observed with the EPICure and EPICure 2 data.

There is a need to explore new avenues in neonatal care that can reduce the long term neurodevelopment complications of extremely preterm birth. One area that has received little attention is that of inter-hospital transfer of these preterm babies. In the UK, like other countries such as USA and Australia, the centralisation of neonatal intensive care in large tertiary units (NICU's) has resulted in reduced mortality but not significant morbidity. Data from Australia suggests there is 4-fold increase in death for those ELBW infants transferred between tertiary neonatal units within the same city (Melbourne). Furthermore, data from the USA, where 69,000 neonatal transports occur each year, have demonstrated a significant increase in severe intraventricular haemorrhages (IVH) in transported infants. Severe IVH is associated with a poor neurological outcome including cerebral palsy. Many of the ELBW infants are transferred within a few hours of life in order to receive specialist care and services. However, it is the first few days of life that represent the greatest risk of developing an IVH with up to 50% developing IVH before 3 days and if severe 75% could go on to develop cerebral palsy.

No causation has been identified for the associated significant increase in risk of IVH and it is likely to be multifactorial. Such factors could include resuscitation at birth and early care on the NICU. However, in developed countries some of these factors are likely to be less important with the establishment of neonatal networks (sharing common practice and guidelines) and international and national guidelines/training programmes for newborn resuscitation. This raises the actual transfer of the preterm infant which could represent a significant stress to the infant. Inter-hospital transfer, usually many miles away from the birth hospital, is at a time during early life when transition from fetus to newborn is still occurring and there is often cardiorespiratory instability. The combination of these factors can increase the risk of neurological injury to the immature developing brain, especially during the period of greatest risk of IVH. Although IVH is easy to identify and define as a risk to the long term neurodevelopment of the baby there is also the possibility that more subtle neurological injury can occur. Such injury may not be detectable from ultrasound imaging alone but may require novel biochemical markers that can be detected in the bodily fluids (blood, urine) or by more detailed imaging techniques (magnetic resonance imaging - MRI). A recent study has highlighted this with early markers of stress correlating with poor neurological predictors, such as regional alterations in brain volume (on MRI) and functional motor deficits, in ex-preterm infants at term corrected gestation.

As more ELBW infants are reaching school age, there are growing concerns surrounding the increased in incidence of neurodevelopmental problems in these children. Many predict that such problems may stem from early life exposure to environmental stressors which could potentially have adverse effects on the infant's physiological and neurological stability. The presence of these stressors is very much evident during inter-hospital transportation and on neonatal units where preterm infants are exposed to noise and mechanical vibration.

On all neonatal units, the characteristic loud noises contributed by alarms, ventilators, phones and even conversations often exceed the recommended hourly level of 45 decibels on an A-weighted scale. Excessive noise levels have been shown to increase heart rate in both preterm and term infants. A maturing biphasic pattern with initial cardiac acceleration and rebound deceleration has been observed in higher birth weight infants, this which was absent or milder in ELBW infants. Noise has also been shown to increase blood pressure, increase respiratory rates, and affect sleep cycles. Decreased autonomic and self-regulatory abilities make these ELBW infants vulnerable to high noise levels due to their inability to filter and process noxious stimuli. This could potentially hinder neurodevelopment during such a critical time.

During inter-hospital transfers, infants are continually exposed to prolonged, low-frequency, high amplitude mechanical vibration. This mechanical vibration has been shown to exceed the maximum recommended limit (0.31m/s) for adults. In adult humans and experimental animals this vibration was found to have adverse effects on the cardiovascular function, the nervous system, the thermoregulatory functions, metabolic and endocrine function, and gastrointestinal system. In animal models, short periods of vibration, similar to those experienced by transported infants, there is a deleterious effect on surfactant and respiratory function which is again often requiring support in the early part of a preterm infants life. The implications of vibration may be especially relevant when transporting ELBW infants as it could compromise the stability and observation of the infant in transport.

Whilst the focus on transport is to ensure the safety of the infant we must also explore interventions that can increase comfort, reduce physical stress and improve outcomes. No studies have detailed the combined physical, physiological and biochemical effects of inter-hospital transfer on these infants and their outcomes. Indeed, many studies have documented sound exposure and a limited number have documented vibration (albeit of the transport incubator rather than the baby). None of these studies have addressed this in a detailed and structured way that will allow us to plan interventional strategies aimed at reducing these stressors. Until such detailed data is available it is not possible to undertake trials aimed at reducing the impact of inter-hospital transfer with the aim of improving outcomes.

The present study will be the first to examine the physical forces the baby is exposed to during transfer. We will also combine this with measures of physiological stability (i.e. monitor vital signs and correlate these with physical stressors) as well as measure key biochemical markers in the newborn. These biochemical markers include cortisol (a well described marker of short-term stress)32, copeptin (a marker of newborn stress) and s100b protein in the urine (a marker of neurological injury). Outcome data will also be analysed.

STUDY OBJECTIVES AND PURPOSE Hypothesis Inter-hospital transfer of the ELBW infant in the first days of life will adversely impact on measures of neonatal stress in the short-term.

Aims

The Primary aim is to quantify:

(i) physical stresses experienced by preterm infants during inter-hospital transfer in early life,

Secondary aims are to quantify:

(ii) the physiological and biochemical disruption caused by transfer, (iii) central nervous system dynamics using advanced computational modelling to ascertain the potential impact on brain injury.

STUDY DESIGN This is an observational study that will provide feasibility data for a larger interventional trial with appropriate sample size.

The study has 3 elements:

Study A. Using infant mannequins we will undertake standard inter-hospital journeys similar to those currently undertaken by neonatal transport teams. The mannequin will be equipped with motion detection equipment (accelerometers), positioning devices (GPS) and noise meters. We will examine a number of interventions aimed at reducing transport associated motion. This work will allow us to plan future trials aimed at improving transport comfort, safety and practicality in preterm infants.

Study B. Establish the motion experienced by neonatal patients during current transport methods. This element of the study will quantify multi-directional forces experienced by babies during their transfer. Whilst data is available on vibration of the transport incubator, no study has quantified the actual effects on the baby and the response of key physiological observations (e.g. heart rate and oxygen saturation). Data from this element will capture a range of clinical variables such as gestation, weight and level of support. This data, along with that gathered in Study C, will allow us to develop a computational model of the physical stresses experienced and design better transport systems.

Study C. To quantify, correlate and assess the physiological and biochemical disturbance experienced by preterm infants undergoing inter-hospital transfer. Preterm infants undergoing inter-hospital transfer will be included in this element.

Conditions
Preterm Birth
Keywords
vibration, noise, transfer, intraventricular hemorrhage
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01851668
Study groupRoleWhat they receive
Preterm inter-hospital transferspreterm infants <31 weeks gestation and <=day 3 of life
Preterm infants inbornPreterm infants <31 weeks gestation and <=3 days old born and remaining at same hospital.
Ex-preterm infants back transferedMature ex-preterm infants transferred back to referring hospital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantification of whole body vibration

    Use of multi-axis accelerometers to quantify vibration and shocks experienced by the head, body and incubator. Calculation of A(8) according to ISO.

    Measured: during transfer

Secondary outcomes (5)
  1. Noise exposure

    Measure total noise exposure (dBA) during transfer compared with NICU exposure.

    Measured: During transfer

  2. Cranial ultrasound imaging to quantify/identify intraventricular haemorrhage

    IVH assessment by cranial USS

    Measured: First 28 days of life

  3. Evidence of excess stress or neuronal injury

    Plasma Copeptin and urinary S100b measurements

    Measured: first week following transfer

  4. Quantification of stresses during first week of life

    Validated stressor score

    Measured: 7 days of life

  5. NIRS measurement of cerebral saturations

    Use of NIRS during interhopsital transfer to assess cerebral saturations when compared to control area (thigh)

    Measured: During ambulance transfer

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2013 (estimated)
  2. Study startJun 2013
  3. Primary completion31 Aug 2017
  4. Study completion1 Sep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01851668
Sponsor's protocol ID
12063
Acronym
PremiTranS
Status last verified
Jan 2017
First submitted
8 May 2013
Last updated
12 Sep 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Preterm Birth, run by University of Nottingham at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantification of whole body vibration (time frame: during transfer). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Preterm Infant Transport Stress (PremiTranS) Study | AzTrials